The COO sold half his stock in March and the former CEO and CFO retired near simultaneously last year and sold chunks of their stock for a reason. Helix is a good story. It's just that it is still a ways off from being impactful. If Happy Days were just around the corner, the former CEO and CFO would have probably waited and the COO would not have dumped half his stake in the company. I like it at the new CEO's stock option exercise price of $9.91 per share or a bit lower.
Well, the CEO has been at this a while now trying to turn this company. He owns a bunch of illiquid stock, as does the good doctor. Sometimes, as age 70 looms ever closer, legacy concerns, exit concerns, and what one wants to do w/the rest of their lives (especially when they get no respect from the stock market or public valuation) drives a new calculus. I bet he lets the injection well thing play out a year or two, but after that.............
Looks like an institution has decided to purge its position in the company. Unfortunately, they are not being very smart or price sensitive about how they are doing it. And they may be doing just ahead of a return to positive cash flow in 2Q. Who sells a virtually debt-free company w/close to $2 per share in cash and trading at 0.2 times revenues at this price? IMO it's both a stupid and messy exit of an illiquid position, but it's probably only a rounding error in the PM's overall portfolio and he could probably care less. He just wants out. Hey, I'm happy to take advantage of someone else's carelessness. That's how you make money in the market.
Think it might have something to do w/the U.K. sector of the North Sea being viewed as an even more important (i.e. secure) source of supply of oil for Europe---given recent events.
The U.S. government is a non-functioning, essentially obsolete, entity. 99% of its time and effort is focused on re-election and maintaining a paying job for its body members.
Eastern European Investment Bank is an oxymoron. Kickstarter could raise funding quicker and more efficiently.
like Greenspan yelling irrational exuberance years ago. IBB in line for a big retracement. It's not like this has raced ahead, but they are all likely to get painted w/the same brush when the Fed Head speaks. The Fed should keep its mouth shut regarding the market and specific sectors. Its not their job. They are not Investment Strategists.
Plus there is no share buyback in place this time to help facilitate any institutional exit and support the share price.
Small caps are deadly. Many of them are simply going to go away. If they have cash on the Balance Sheet it may take a little while, but the institutional purge of anything Russell 2000 or smaller is going to be significant.
Not if Janet Yellen has anything to say about it. I'm only half-kidding. With all the hurdles facing this company and this stock, who would have thought the FED Chair would pile on by damning anything biotech, especially anything w/the first three letters B-I-O in its name? The Fed needs to remove itself from such speculation unless Chairman Yellen would prefer to be the Investment Strategist for GS or Merrill.
Lots of guys consider themselves smart traders "selling the news". But the guys that have really made money have been the ones who have held through thick and thin and established a long term capital gain position and enjoyed ever higher dividends. For every trader that makes "good money despite paying the higher capital gains tax rate from whipping stocks short term", there are probably 10 that underperform.
Every single rally since mid-January has been sold. That trend continues almost on a daily basis. I think there have been only two days in the past six months where the stock closed at its high of the day. I believe an institution is chipping away its position at every opportunity--sometimes a little higher when a positive SA article adds some liquidity, sometimes a little lower when it's quiet. They have to take what the market gives them, and it's usually only 10,000 -20,000 shares a day unless they want to blow up the share price.
I'm interested at the CEO's stock option exercise price of $9.91 per share. I'd be satisfied to be on the same cost basis as him, and assume he would initiate some defensive action (e.g. buyback) near that level to keep the stock from falling much below it. That's a price where I see low risk and decent upside. Right now it is tough to bet against the selling that has a six month tail on it, down from the high of $18.24. I passed on the stock when it hit $10 back in early May as I was looking for a dime lower.
Dude got "gifted" an option for 100,000 shares at a $9.91 exercise price pretty much as he walked through the door, having done nothing yet. You want his price. That's the price you want to buy at--$9.91 per share to be on the same footing as him. Thinks he also gets options the next couple years for another 100,000 shares each year. You want the same price he gets for the strike price each year. Accumulating on that (i.e., his) basis each year is not the worst idea.
Still a chance you can buy it in the $9s if the range gets violated to the downside. Want the CEO's option price of $9.91 per share---not a penny more.